NEA 14 - IMARA INC. -- SCHEDULE 13D

Company

Enliven Therapeutics, Inc.

Filed

March 20, 2020

Accession Number

0001072613-20-000132

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →